Vaneck Biotech ETF (BBH)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Phone: 888-658-8287
MacroHard26
MacroHard26 Jun. 1 at 5:40 PM
$RVMD $XBI $BBH $SPY $LABU Charles Zhu Reiterates Buy on RVMD, Maintains $263 Price Target on Strong Darax. Data and Regulatory Progress Revolution Medicines Is Maintained at Outperform by Oppenheimer $RVMD Wedbush reiterates Outperform on Revolution Medicines after ASCO data Revolution Medicines price target raised to $195 from $169 at H.C. Wainwright Wells Fargo Sticks to Its Buy Rating for Revolution Medicines (RVMD) Ami Fadia Reiterates Buy on Strong Daraxonrasib Data, Maintains $183 Price Target
0 · Reply
MacroHard26
MacroHard26 Jun. 1 at 1:35 PM
$RVMD $SPY $IBB $XBI $BBH $RVMD - Revolutionary https://finance.yahoo.com/sectors/healthcare/articles/revolution-medicines-pancreatic-cancer-pill-024312342.html
0 · Reply
StocktwitsNews
StocktwitsNews May. 22 at 7:08 PM
GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment $GILD $BBH $IBB https://stocktwits.com/news/equity/markets/gild-stock-jumps-after-winning-accelerated-fda-approval-for-hdv-treatment/cZgRlDmReYE
0 · Reply
Makingmillions192
Makingmillions192 Apr. 23 at 2:23 PM
$LEXX Biotech is a clear 2026 & 2027 winner 🔥 Right place, right time, rising tide 📈 $XBI $IBB $BBH
0 · Reply
Billianas
Billianas Apr. 10 at 12:49 PM
$ABVX can drop as quick as it jumped. $XBI $IBB $BBH $FBT
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 27 at 12:29 AM
$BBH Share Price: $184.90 Contract Selected: Sep 18, 2026 $185 Calls Buy Zone: $10.20 – $12.60 Target Zone: $19.11 – $23.35 Potential Upside: 77% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 22 at 5:27 PM
$BBH Current Stock Price: $197.25 Contracts to trade: $195.0 BBH Mar 20 2026 Call Entry: $4.50 Exit: $6.41 ROI: 43% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 22 at 2:26 PM
$BBH Share Price: $197.25 Contract Selected: Sep 18, 2026 $210 Calls Buy Zone: $5.95 – $7.35 Target Zone: $11.24 – $13.74 Potential Upside: 78% ROI Time to Expiration: 207 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 10 at 12:36 PM
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? $PLRZ $BBH $IBB https://stocktwits.com/news/equity/markets/why-did-plrz-stock-gain-premarket/cZbU3zNR4Yr
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 10 at 2:31 AM
$BBH Current Stock Price: $198.18 Contracts to trade: $195.0 BBH Feb 20 2026 Call Entry: $3.00 Exit: $5.67 ROI: 89% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on BBH
VanEck Announces Year-End Distributions for VanEck Equity ETFs

Dec 19, 2025, 8:24 PM EST - 5 months ago

VanEck Announces Year-End Distributions for VanEck Equity ETFs

AFK BRF BUZZ CNXT CRAK DAPP DGIN

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

Sep 3, 2025, 3:32 PM EDT - 9 months ago

Real assets in biotech serving big markets the Street is finally noticing, says Mizuho's Jared Holz

ARGX BMRN CYTK IBB XBI

ETF Investors Indicate Active Strategies and Product Innovation Will Fuel the Industry's Continued Growth: BBH 2024 Global ETF Investor Survey

May 21, 2024, 8:00 AM EDT - 2 years ago

ETF Investors Indicate Active Strategies and Product Innovation Will Fuel the Industry's Continued Growth: BBH 2024 Global ETF Investor Survey

Brown Brothers Harriman Private Banking Team Expands in Philadelphia

Jan 23, 2023, 9:00 AM EST - 3 years ago

Brown Brothers Harriman Private Banking Team Expands in Philadelphia

VanEck Announces Yearend Distributions for VanEck Equity ETFs

Dec 16, 2022, 7:19 PM EST - 3 years ago

VanEck Announces Yearend Distributions for VanEck Equity ETFs

AFK BRF BUZZ CNXT CRAK DAPP DGIN

9 Best Biotech ETFs to Play High-Octane Trends

Jul 8, 2021, 3:57 PM EDT - 5 years ago

9 Best Biotech ETFs to Play High-Octane Trends

ARKG CNCR IBB IDNA PBE SBIO XBI

Biotech ETFs at multi-week highs, extending winning streak

Oct 27, 2020, 1:45 PM EDT - 6 years ago

Biotech ETFs at multi-week highs, extending winning streak

FBT IBB XBI

Coronavirus treatment: FDA authorizes convalescent plasma for COVID-19 use

Aug 24, 2020, 10:07 AM EDT - 6 years ago

Coronavirus treatment: FDA authorizes convalescent plasma for COVID-19 use

IBB XBI

MacroHard26
MacroHard26 Jun. 1 at 5:40 PM
$RVMD $XBI $BBH $SPY $LABU Charles Zhu Reiterates Buy on RVMD, Maintains $263 Price Target on Strong Darax. Data and Regulatory Progress Revolution Medicines Is Maintained at Outperform by Oppenheimer $RVMD Wedbush reiterates Outperform on Revolution Medicines after ASCO data Revolution Medicines price target raised to $195 from $169 at H.C. Wainwright Wells Fargo Sticks to Its Buy Rating for Revolution Medicines (RVMD) Ami Fadia Reiterates Buy on Strong Daraxonrasib Data, Maintains $183 Price Target
0 · Reply
MacroHard26
MacroHard26 Jun. 1 at 1:35 PM
$RVMD $SPY $IBB $XBI $BBH $RVMD - Revolutionary https://finance.yahoo.com/sectors/healthcare/articles/revolution-medicines-pancreatic-cancer-pill-024312342.html
0 · Reply
StocktwitsNews
StocktwitsNews May. 22 at 7:08 PM
GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment $GILD $BBH $IBB https://stocktwits.com/news/equity/markets/gild-stock-jumps-after-winning-accelerated-fda-approval-for-hdv-treatment/cZgRlDmReYE
0 · Reply
Makingmillions192
Makingmillions192 Apr. 23 at 2:23 PM
$LEXX Biotech is a clear 2026 & 2027 winner 🔥 Right place, right time, rising tide 📈 $XBI $IBB $BBH
0 · Reply
Billianas
Billianas Apr. 10 at 12:49 PM
$ABVX can drop as quick as it jumped. $XBI $IBB $BBH $FBT
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 27 at 12:29 AM
$BBH Share Price: $184.90 Contract Selected: Sep 18, 2026 $185 Calls Buy Zone: $10.20 – $12.60 Target Zone: $19.11 – $23.35 Potential Upside: 77% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 22 at 5:27 PM
$BBH Current Stock Price: $197.25 Contracts to trade: $195.0 BBH Mar 20 2026 Call Entry: $4.50 Exit: $6.41 ROI: 43% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 22 at 2:26 PM
$BBH Share Price: $197.25 Contract Selected: Sep 18, 2026 $210 Calls Buy Zone: $5.95 – $7.35 Target Zone: $11.24 – $13.74 Potential Upside: 78% ROI Time to Expiration: 207 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 10 at 12:36 PM
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? $PLRZ $BBH $IBB https://stocktwits.com/news/equity/markets/why-did-plrz-stock-gain-premarket/cZbU3zNR4Yr
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 10 at 2:31 AM
$BBH Current Stock Price: $198.18 Contracts to trade: $195.0 BBH Feb 20 2026 Call Entry: $3.00 Exit: $5.67 ROI: 89% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 30 at 1:16 PM
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock $REGN $BBH $IBB $THNR https://stocktwits.com/news/equity/markets/regn-stock-slips-regeneron-earnings-q4-eylea-hd-revenue/cmySjWfR4S5
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 24 at 6:47 PM
$BBH Share Price: $197.52 Contract Selected: Jun 18, 2026 $200 Calls Buy Zone: $7.22 – $8.93 Target Zone: $12.67 – $15.49 Potential Upside: 66% ROI Time to Expiration: 144 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
rachelstocks
rachelstocks Jan. 3 at 3:34 PM
$AMGN $BBH $REGN $SPY $VRTX 👀 good stuff
1 · Reply
eWhispers
eWhispers Jan. 3 at 3:08 PM
83% of Biotech stocks in $BBH have outperformed the S&P 500 $SPY over the past quarter, yet it remains when of the most disliked groups. In fact, sentiment remains near Liberation Day lows. You'll have to wait until February to get a look at their fourth quarter earnings, but that's a lot of time to drift. https://www.earningswhispers.com/wrs $REGN $VRTX $AMGN
0 · Reply
LogicLuster
LogicLuster Dec. 27 at 12:38 PM
$BBH Valuation sensitivity is high because visibility is uneven; pipeline visibility needs clearer corroboration — improving transparency could compress perceived risk. Until validation appears, volatility remains the default.
0 · Reply
BigBlocKBuyer
BigBlocKBuyer Nov. 11 at 5:57 PM
$IWM $BBH noticing significant rotation into Heavy weighted Russell 2000 small cap biotechs today. Does this rotation help the small cap rally or just a one day blip?
0 · Reply
Friendlyfox
Friendlyfox Nov. 2 at 1:45 AM
$BBH
0 · Reply
PineGate
PineGate Oct. 8 at 7:36 PM
$XBI $BBH $REGN $MRNA Calling the pancreatic program “high risk” ignores the latest data: the lead blood-based biomarker panel just posted 100% sensitivity / 95% specificity in feasibility and detected precancerous lesions. Next steps are already mapped: larger retrospective cohort (NGS to lock the panel) to PCR-based validation for scale (lower cost, fast TAT, ubiquitous lab hardware). That’s textbook de-risking from signal and product path, not hype
0 · Reply